ArticleMolecular diversity2026
Antitarget profiling of mycotoxins via molecular docking.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Chemical Scaffold to Predicted Toxicity: A Scaffold-Aware Pipeline for Reliable In Silico Prioritization ofInternational journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding the molecular mechanisms underlying mycotoxin toxicity is crucial for risk assessment and public health protection. In this study, we performed comprehensive molecular docking analysis of 434 structurally diverse mycotoxins against a panel of 44 human protein targets associated with acute toxicity effects. Docking results revealed that 18.2% of all interactions had binding energies ≤ -9 kcal/mol. We identified which proteins across the panel were most vulnerable to mycotoxins: acetylcholinesterase, serotonin transporter, and adrenergic receptors (ADRB1 and ADRB2). Analysis identified most promiscuous mycotoxins, including β-asperlicin C and ergotamine, the latter demonstrating the most favorable predicted binding to HTR1B ([Formula: see text] kcal/mol), consistent with experimental data. Class-specific binding pattern analysis revealed that aflatoxins and ochratoxins exhibit broad multi-target activity. These findings provide systematic insights into the molecular basis of mycotoxin toxicity and identify priority targets for future experimental validation and public health monitoring strategies. The dataset containing the affinity data is publicly available at https://github.com/chemagents/mycotoxins-antitargets.
Indexed as
Identifiers
41961392What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.